BIOR: Capitalizing on Progress: BT-600 to Start
By John Vandermosten, CFA
NASDAQ:BIOR
READ THE FULL BIOR RESEARCH REPORT
Update on Programs and Capital Structure
Following the report of third quarter financial and operational results, Biora...
BCTX: Down in San Antone
By John Vandermosten, CFA
NASDAQ:BCTX
San Antonio Breast Cancer Symposium Poster Presentations
BriaCell Therapeutics Corp. (NASDAQ:BCTX) presented three posters at the 2023 San Antonio Breast Cancer Symposium...
ACHV: Not So Fast…
By John Vandermosten, CFA
NASDAQ:ACHV
READ THE FULL ACHV RESEARCH REPORT
Update to the Timeline
On December 11th, 2023, Achieve Life Sciences, Inc. (NASDAQ:ACHV) filed Form 8-K updating...
XFOR: Update on Phase 2 CN Trial at ASH 2023
By David Bautz, PhD
NASDAQ:XFOR
READ THE FULL XFOR RESEARCH REPORT
Business Update
Case Studies of First Three Patients from Phase 2 CN Trial Presented at ASH 2023
On...
FMST: Lithium Prices Decline Creating Potential for Low Cost Entry Points in North American Hard-Rock Lithium Junior Mining Companies
By Steven Ralston, CFA
NASDAQ:FMSTCSE:FAT
From the beginning of 2021 and the end of 2022, the price of lithium skyrocketed over 900% as the transition to...
